ArticleThe American journal of pathology2013

Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Steven Pennock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.